A Modified Blumgart Pancreaticojejunostomy in Laparoscopic Pancreaticoduodenectomy: A Retrospective Study
World Journal of Surgery · 08.11.2026
DOI: 10.1002/wjs.70659 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 08.11.2026. Verfasst von Lukang Teng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Tumor Surgery, College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science …. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Laparoscopic pancreaticoduodenectomy (LPD) is increasingly performed, but clinically relevant postoperative pancreatic fistula (CR‐POPF) remains a major complication. This study evaluated a modified Blumgart pancreaticojejunostomy (PJ) technique in LPD.
Methods
This retrospective study included 217 consecutive patients who underwent LPD between January 2021 and December 2025. 102 in the modified Blumgart group and 115 in the conventional Blumgart group. 1:1 propensity score matching (PSM) was performed using 12 covariates based on the Fistula Risk Score model. The primary outcome was CR‐POPF. Univariate and multivariate logistic regression identified independent risk factors, and exploratory subgroup analyses were conducted.
Results
After PSM, 78 patients remained in each group. In the entire cohort, the modified group had a significantly lower CR‐POPF rate (6.9% vs. 17.4%, p = 0.019) and fewer abdominal infections (5.9% vs. 15.7%, p = 0.022). After PSM, CR‐POPF remained lower in the modified group (7.7% vs. 17.9%, p = 0.055), and abdominal infection remained significantly reduced (6.4% vs. 16.7%, p = 0.045). Multivariate analysis identified PDAC pathology (OR = 0.233, p = 0.022) and modified anastomosis (OR = 0.383, p = 0.041) as independent protective factors in the entire cohort. Subgroup analysis revealed that the protective effect was shown in patients with a main pancreatic duct > 3 mm (OR = 0.176, p = 0.008; PSM cohort: OR = 0.169, p = 0.027; p for interaction = 0.070 and 0.111, respectively).
Conclusions
The modified Blumgart PJ is safe and effective in LPD, reducing CR‐POPF and abdominal infection. Its protective effect is shown in patients with a main pancreatic duct > 3 mm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Tumor Surgery, College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science and Technology, Henan University of Science and Technology, Luoyang, C…
ORCID-Profile: Lukang Teng, Shupeng Wang
Zitieren
APA
Teng, L., Wang, S., Li, H., Yang, J., Zhou, H., Fan, Y., & Yao, G. (2026). A Modified Blumgart Pancreaticojejunostomy in Laparoscopic Pancreaticoduodenectomy: A Retrospective Study. World Journal of Surgery. https://doi.org/10.1002/wjs.70659
Vancouver
Teng L, Wang S, Li H, Yang J, Zhou H, Fan Y, et al. A Modified Blumgart Pancreaticojejunostomy in Laparoscopic Pancreaticoduodenectomy: A Retrospective Study. World Journal of Surgery. 2026. doi:10.1002/wjs.70659
BibTeX
@article{Teng2026,
author = {Teng, Lukang and Wang, Shupeng and Li, Hongbo and Yang, Junna and Zhou, He and Fan, Yonggang and Yao, Guoliang},
title = {A Modified Blumgart Pancreaticojejunostomy in Laparoscopic Pancreaticoduodenectomy: A Retrospective Study},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70659}
}
EUVIMED